{"patient_id": "P001", "mrn": "MDA-1001", "source": "Source-A", "oncologist_id": "ONC-A", "oncologist_name": "Dr. Alvarez", "note_datetime": "2024-10-27T16:45:00", "section": "Labs", "text": "Imaging report: MRI brain shows stable disease. RECIST target CR.", "provenance": {"ingested_from": "/sources/A/P001.txt", "checksum": "0x72ff5d2a386ecbe0"}}
{"patient_id": "P001", "mrn": "MDA-1001", "source": "Source-A", "oncologist_id": "ONC-A", "oncologist_name": "Dr. Alvarez", "note_datetime": "2023-05-08T14:00:00", "section": "Treatment", "text": "Treatment note: Started R-ABVD cycle 1. Premeds given. Tolerated poorly (dose reduce).", "provenance": {"ingested_from": "/sources/A/P001.txt", "checksum": "0x4b0dbb418d5288f1"}}
{"patient_id": "P002", "mrn": "MDA-1002", "source": "Source-A", "oncologist_id": "ONC-A", "oncologist_name": "Dr. Alvarez", "note_datetime": "2023-10-01T09:15:00", "section": "Labs", "text": "Imaging report: CT A/P shows partial response (~20% shrink). RECIST target PD.", "provenance": {"ingested_from": "/sources/A/P002.txt", "checksum": "0xbaa80dd488bd6407"}}
{"patient_id": "P002", "mrn": "MDA-1002", "source": "Source-A", "oncologist_id": "ONC-A", "oncologist_name": "Dr. Alvarez", "note_datetime": "2024-11-02T15:45:00", "section": "Assessment/Plan", "text": "Pathology: colon sigmoid biopsy adenocarcinoma. Markers: EGFR wild-type; ALK neg; PD-L1 5%.", "provenance": {"ingested_from": "/sources/A/P002.txt", "checksum": "0xea1fca65e27a984d"}}
{"patient_id": "P002", "mrn": "MDA-1002", "source": "Source-A", "oncologist_id": "ONC-A", "oncologist_name": "Dr. Alvarez", "note_datetime": "2025-05-31T09:15:00", "section": "HPI", "text": "Clinic note: NSCLC, adenocarcinoma. Staging IV. ECOG 2. Weight 59kg. dyspnea on exertion. Plan: consider gemcitabine/nab-paclitaxel.", "provenance": {"ingested_from": "/sources/A/P002.txt", "checksum": "0x28f49481a0a04dc4"}}
